Your browser doesn't support javascript.
loading
Identification of Novel Drug Candidate for Epithelial Ovarian Cancer via In Silico Investigation and In Vitro Validation.
Zou, Dan; Bai, Jin; Lu, Enting; Yang, Chunjiao; Liu, Jiaqing; Wen, Zhenpeng; Liu, Xuqin; Jin, Zi; Xu, Mengdan; Jiang, Lei; Zhang, Ye; Zhang, Yi.
Afiliação
  • Zou D; The First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang, China.
  • Bai J; Department of Medical Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China.
  • Lu E; The First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang, China.
  • Yang C; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
  • Liu J; Department of Gynecology, First Hospital of China Medical University, Shenyang, China.
  • Wen Z; The First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang, China.
  • Liu X; The First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang, China.
  • Jin Z; The First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang, China.
  • Xu M; The First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang, China.
  • Jiang L; The First Department of Oncology, Shenyang Fifth People's Hospital, Shenyang, China.
  • Zhang Y; The First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang, China.
  • Zhang Y; The First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang, China.
Front Oncol ; 11: 745590, 2021.
Article em En | MEDLINE | ID: mdl-34745968

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça